| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
4,528
|
5,501
|
5,686
|
4,524
| | Cost of Revenue | 2,027 | 1,702 | 3,296 | 2,531 | | |
Gross Profit
|
2,501
|
3,799
|
2,389
|
1,993
| |
|
Operating Expenses |
|
Research Development | 3,073 | 5,661 | 3,900 | 2,483 |
|
Selling General and Administrative | 2,832 | 3,183 | 2,008 | 2,301 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(3,403)
|
(5,045)
|
(3,519)
|
(2,791)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (5) | 33 | (15) | (17) |
|
Earnings Before Interest And Taxes | (3,408) | (5,012) | (3,534) | (2,807) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (3,408) | (5,012) | (3,534) | (2,807) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (3,408) | (5,012) | (3,534) | (2,807) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(3,408)
|
(5,012)
|
(3,534)
|
(2,807)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(3,408)
|
(5,012)
|
(3,534)
|
(2,807)
|
|
0.01(0.24%) 3:49PM EDT - Nasdaq Real Time Price